Book Store

The Potential of the Biofield Energy Treated Novel Propriety Test Formulation on Organ Specific Biomarkers

by Inthirani Arul


au Buy Now ca Buy Now de Buy Now uk Buy Now us Buy Now

“The study was investigated to find out the impact of the Biofield Energy Treated test formulation on the function of vital organs viz. bones, heart, liver, lungs, and brain in various cell-based assays. The test formulation and the cell media was divided into two parts; one untreated (UT) and other part received the Biofield Energy Treatment remotely by a renowned Biofield Energy Healer, Inthirani Arul, Canada and was labeled as the Biofield Energy Treated (BT) test formulation/media. Cell viability data suggested that the test formulation was safe and non-toxic in nature in six different cells. The Biofield Energy Treated medium (BT-Med) + untreated test item (UT-TI) group showed 97.9% and 88.9% restoration of cell viability at 10 and 25 µg/mL, respectively as compared to the UT-Med + UT-TI group in human cardiac fibroblasts cells (HCF). Moreover, BT-Med + BT-TI group showed 62.8% and 86.2% restoration of cell viability at 1 and 63 µg/mL, respectively in human hepatoma cells (HepG2) compared to untreated. Furthermore, 125.6% (at 0.1 µg/mL) and 94.8% (at 63 µg/mL) restoration of cell viability was observed in adenocarcinomic human alveolar basal epithelial cells (A549) by UT-Med[…]”

Excerpt From: Inthirani Arul. “The Potential of the Biofield Energy Treated Novel Proprietary Test Formulation on Organs Specific Biomarkers.” Apple Books.

© Copyright | Privacy Policy
Evolve Systems Group Pty Ltd
ABN: 51 098 121 343

Use of this Web site constitutes your acceptance of our Terms and Conditions /Privacy Policy and trademarks and brands are the property of their respective owners. 

This site is not a part of the Facebook website or Facebook, Inc.  Additionally, this site is not endorsed by Facebook in any way. Facebook is a trademark of Facebook, Inc.

Contact Us

Phone: 1300 889 383




Copyright © 2020 Evolvepreneur - All rights reserved.
Got A Question